Advanced Enzyme Technologies Limited — PPTs, 09-11-2024: Investor Presentation

Advanced Enzyme Technologies Limited reported a 7% year-on-year revenue decline, amounting to ₹1,461 million for Q2 FY25, with EBITDA dropping 17% to ₹424 million. PAT decreased by 5% to ₹334 million. Despite these declines, the company saw a 6% increase in PAT for the first half of FY25 compared to the previous year, totaling ₹684 million. The human nutrition segment remains a key contributor, accounting for approximately 68% of revenue.